{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:16:28Z","timestamp":1788430588590,"version":"build-2803163510"},"reference-count":219,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015361","name":"University of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2024HIAS-Y013"],"award-info":[{"award-number":["2024HIAS-Y013"]}],"id":[{"id":"10.13039\/501100015361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.lfs.2026.124397","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:23:58Z","timestamp":1776284638000},"page":"124397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The aggregation of amyloid-\u03b2: from condensation, nucleation, and conformation to targeting therapy"],"prefix":"10.1016","volume":"396","author":[{"given":"Bangyao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiancheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2026.124397_bb0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(02)09420-5","article-title":"Alzheimer's disease","volume":"360","author":"Burns","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2026.124397_bb0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2026.124397_bb0015","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jamaneurol.2016.2078","article-title":"Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between \u03b2-Amyloid and Tauopathy","volume":"73","author":"Wang","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.lfs.2026.124397_bb0020","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.lfs.2026.124397_bb0025","doi-asserted-by":"crossref","first-page":"eadp2564","DOI":"10.1126\/scitranslmed.adp2564","article-title":"Amyloid-associated hyperconnectivity drives tau spread across connected brain regions in Alzheimer\u2019s disease","volume":"17","author":"Roemer-Cassiano","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lfs.2026.124397_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110179","article-title":"Critical aggregation concentration and reversibility of amyloid-\u03b2 (1-40) oligomers","volume":"761","author":"Illodo","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.lfs.2026.124397_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105208","article-title":"Aggregation and structure of amyloid \u03b2-protein","volume":"151","author":"Ono","year":"2021","journal-title":"Neurochem. Int."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2026.124397_bb0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1471-4159.2011.07478.x","article-title":"Soluble A\u03b2 oligomer production and toxicity","volume":"120","author":"Larson","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2026.124397_bb0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/bs.ircmb.2016.08.014","article-title":"The Nucleation of Protein Aggregates - From Crystals to Amyloid Fibrils","volume":"329","author":"Buell","year":"2017","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2026.124397_bb0050","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.1073\/pnas.1218402110","article-title":"Proliferation of amyloid-\u03b242 aggregates occurs through a secondary nucleation mechanism","volume":"110","author":"Cohen","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2026.124397_bb0055","doi-asserted-by":"crossref","first-page":"41443","DOI":"10.1074\/jbc.M110.141390","article-title":"The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a {beta}-secretase-dependent pathway","volume":"285","author":"Belyaev","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fnmol.2017.00030","article-title":"Therapeutic Potential of Secreted Amyloid Precursor Protein APPs\u03b1","volume":"10","author":"Mockett","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2026.124397_bb0065","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2026.124397_bb0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2026.124397_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102599","article-title":"An overview of the genes and biomarkers in Alzheimer\u2019s disease","volume":"104","author":"Krishnamurthy","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.lfs.2026.124397_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041413","article-title":"APP Osaka Mutation in Familial Alzheimer\u2019s Disease-Its Discovery, Phenotypes, and Mechanism of Recessive Inheritance","volume":"21","author":"Tomiyama","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2026.124397_bb0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-024-01659-6","article-title":"Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer\u2019s disease","volume":"17","author":"Valdes","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.lfs.2026.124397_bb0090","first-page":"141","article-title":"Loss-of-function presenilin mutations in Alzheimer disease","volume":"8","author":"De Strooper","year":"2007","journal-title":"Talking Point on the role of presenilin mutations in Alzheimer disease, EMBO reports."},{"key":"10.1016\/j.lfs.2026.124397_bb0095","doi-asserted-by":"crossref","first-page":"35352","DOI":"10.1074\/jbc.M507217200","article-title":"A nine-transmembrane domain topology for presenilin 1","volume":"280","author":"Laudon","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0100","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1471-4159.2004.02858.x","article-title":"Presenilin 2 familial Alzheimer\u2019s disease mutations result in partial loss of function and dramatic changes in Abeta 42\/40 ratios","volume":"92","author":"Walker","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2026.124397_bb0105","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/s41598-018-19961-3","article-title":"Critical aggregation concentration for the formation of early Amyloid-\u03b2 (1-42) oligomers","volume":"8","author":"Novo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2026.124397_bb0110","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nprot.2016.010","article-title":"Molecular mechanisms of protein aggregation from global fitting of kinetic models","volume":"11","author":"Meisl","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.lfs.2026.124397_bb0115","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1021\/acs.jpclett.2c00685","article-title":"Multiscale Exploration of Concentration-Dependent Amyloid-\u03b2(16-21) Amyloid Nucleation","volume":"13","author":"Tang","year":"2022","journal-title":"The journal of physical chemistry letters."},{"key":"10.1016\/j.lfs.2026.124397_bb0120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12551-017-0353-8","article-title":"Recent progress on understanding the mechanisms of amyloid nucleation","volume":"10","author":"Chatani","year":"2018","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.lfs.2026.124397_bb0125","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.1039\/C4CP05563B","article-title":"On the lag phase in amyloid fibril formation","volume":"17","author":"Arosio","year":"2015","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.lfs.2026.124397_bb0130","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1074\/jbc.RA120.013459","article-title":"Amyloid-\u03b2 oligomers are captured by the DNAJB6 chaperone: Direct detection of interactions that can prevent primary nucleation","volume":"295","author":"\u00d6sterlund","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0135","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00018-010-0529-x","article-title":"Transformation of amyloid \u03b2(1-40) oligomers into fibrils is characterized by a major change in secondary structure","volume":"68","author":"Sarroukh","year":"2011","journal-title":"Cellular and molecular life sciences : CMLS."},{"key":"10.1016\/j.lfs.2026.124397_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202210675","article-title":"pH Dependence of Amyloid-\u03b2 Fibril Assembly Kinetics: Unravelling the Microscopic Molecular Processes","volume":"61","author":"Tian","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.lfs.2026.124397_bb0145","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/pro.3674","article-title":"\u03b2-Amyloid aggregation and heterogeneous nucleation","volume":"28","author":"Srivastava","year":"2019","journal-title":"Protein Sci."},{"key":"10.1016\/j.lfs.2026.124397_bb0150","doi-asserted-by":"crossref","DOI":"10.1063\/1.4995255","article-title":"Mechanisms and rates of nucleation of amyloid fibrils","volume":"147","author":"Lee","year":"2017","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.lfs.2026.124397_bb0155","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41557-018-0023-x","article-title":"Distinct thermodynamic signatures of oligomer generation in the aggregation of the amyloid-\u03b2 peptide","volume":"10","author":"Cohen","year":"2018","journal-title":"Nat. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0160","doi-asserted-by":"crossref","first-page":"eaav8216","DOI":"10.1126\/sciadv.aav8216","article-title":"Molecular insights into the surface-catalyzed secondary nucleation of amyloid-\u03b2(40) (A\u03b2(40)) by the peptide fragment A\u03b2(16-22)","volume":"5","author":"Bunce","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.lfs.2026.124397_bb0165","doi-asserted-by":"crossref","first-page":"eaau3112","DOI":"10.1126\/sciadv.aau3112","article-title":"Secondary nucleation and elongation occur at different sites on Alzheimer\u2019s amyloid-\u03b2 aggregates","volume":"5","author":"Scheidt","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.lfs.2026.124397_bb0170","doi-asserted-by":"crossref","unstructured":"N. Meyer, N. Arroyo, L. Roustan, J.M. Janot, S. Charles-Achille, J. Torrent, F. Picaud, S. Balme, Secondary nucleation of A\u03b2 revealed by single-molecule and computational approaches, Advanced science (Weinheim, Baden-Wurttemberg, Germany). vol. 11 (2024) e2404916. doi:https:\/\/doi.org\/10.1002\/advs.202404916, Adv. Sci..","DOI":"10.1002\/advs.202404916"},{"key":"10.1016\/j.lfs.2026.124397_bb0175","doi-asserted-by":"crossref","first-page":"16621","DOI":"10.1021\/jacs.1c07228","article-title":"Mechanism of Secondary Nucleation at the Single Fibril Level from Direct Observations of A\u03b242 Aggregation","volume":"143","author":"Zimmermann","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.lfs.2026.124397_bb0180","doi-asserted-by":"crossref","first-page":"eadp5059","DOI":"10.1126\/sciadv.adp5059","article-title":"Accelerated Alzheimer\u2019s A\u03b2-42 secondary nucleation chronologically visualized on fibril surfaces","volume":"10","author":"Nirmalraj","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.lfs.2026.124397_bb0185","doi-asserted-by":"crossref","first-page":"22633","DOI":"10.1038\/s41598-024-72265-7","article-title":"Aggregation of the amyloid-\u03b2 peptide (A\u03b240) within condensates generated through liquid\u2013liquid phase separation","volume":"14","author":"Morris","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2026.124397_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.102926","article-title":"Liquid-liquid phase separation of amyloid-\u03b2 oligomers modulates amyloid fibrils formation","volume":"299","author":"Gui","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0195","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1021\/acschemneuro.3c00286","article-title":"Liquid\u2013liquid phase separation (LLPS)-driven fibrilization of amyloid-\u03b2 protein","volume":"14","author":"Sudhakar","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.lfs.2026.124397_bb0200","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1039\/D4SM00470A","article-title":"Liquid\u2013liquid phase separation induced by crowding condition affects amyloid-\u03b2 aggregation mechanism","volume":"20","author":"Kobayashi","year":"2024","journal-title":"Soft Matter"},{"key":"10.1016\/j.lfs.2026.124397_bb0205","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1471-4159.2012.07847.x","article-title":"Cross-seeding effects of amyloid \u03b2-protein and \u03b1-synuclein","volume":"122","author":"Ono","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2026.124397_bb0210","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1002\/1873-3468.70118","article-title":"A\u03b242 promotes the aggregation of \u03b1-synuclein splice isoforms via heterogeneous nucleation","volume":"599","author":"R\u00f6ntgen","year":"2025","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2026.124397_bb0215","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1021\/acscentsci.5c00614","article-title":"Recruitment of A\u03b2 into \u03b1-Synuclein Condensates Catalyzes Primary Nucleation of \u03b1-Synuclein Aggregation","volume":"11","author":"Morris","year":"2025","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.lfs.2026.124397_bb0220","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2401307122","article-title":"Lipid-induced condensate formation from the Alzheimer's A\u03b2 peptide triggers amyloid aggregation","volume":"122","author":"\u0160neiderien\u0117","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2026.124397_bb0225","doi-asserted-by":"crossref","first-page":"33090","DOI":"10.1073\/pnas.2007694117","article-title":"Physical mechanisms of amyloid nucleation on fluid membranes","volume":"117","author":"Krausser","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2026.124397_bb0230","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s42004-025-01537-8","article-title":"Structural convergence and membrane interactions of A\u03b2(1-42) along the primary nucleation process studied by solid state NMR","volume":"8","author":"Kengwerere","year":"2025","journal-title":"Communications chemistry."},{"key":"10.1016\/j.lfs.2026.124397_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102491","article-title":"Early stage \u03b2-amyloid-membrane interactions modulate lipid dynamics and influence structural interfaces and fibrillation","volume":"298","author":"Kenyaga","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0240","article-title":"Imaging Amyloid-\u03b2 Membrane Interactions: Ion-Channel Pores and Lipid-Bilayer Permeability in Alzheimer's Disease","volume":"62","author":"Viles","year":"2023","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.lfs.2026.124397_bb0245","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/alzrt258","article-title":"Truncated and modified amyloid-beta species","volume":"6","author":"Kummer","year":"2014","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.lfs.2026.124397_bb0250","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/14728222.2019.1702972","article-title":"Emerging roles of N- and C-terminally truncated A\u03b2 species in Alzheimer\u2019s disease","volume":"23","author":"Wirths","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.lfs.2026.124397_bb0255","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbadis.2017.07.005","article-title":"A\u03b2 truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition","volume":"1864","author":"Cabrera","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.lfs.2026.124397_bb0260","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1021\/cn3000982","article-title":"Amyloid \u03b2-peptide 25-35 self-assembly and its inhibition: a model undecapeptide system to gain atomistic and secondary structure details of the Alzheimer's disease process and treatment","volume":"3","author":"Naldi","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.lfs.2026.124397_bb0265","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.colsurfb.2016.01.015","article-title":"Interaction of the Alzheimer A\u03b2(25-35) peptide segment with model membranes","volume":"141","author":"Cuco","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.lfs.2026.124397_bb0270","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2011.09.071","article-title":"Pyroglutamate-A\u03b2 3 and 11 colocalize in amyloid plaques in Alzheimer\u2019s disease cerebral cortex with pyroglutamate-A\u03b2 11 forming the central core","volume":"505","author":"Sullivan","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2026.124397_bb0275","doi-asserted-by":"crossref","first-page":"10871","DOI":"10.1021\/bi990563r","article-title":"The A beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length A beta","volume":"38","author":"He","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.lfs.2026.124397_bb0280","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1074\/jbc.M110.185819","article-title":"Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice","volume":"286","author":"Jawhar","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0285","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3390\/biomedicines13061467","article-title":"An Overview of Glutaminyl Cyclase as a Promising Drug Target for Alzheimer\u2019s Disease","volume":"13","author":"Madhusudhana","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.lfs.2026.124397_bb0290","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/nm.1872","article-title":"Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer\u2019s disease-like pathology","volume":"14","author":"Schilling","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2026.124397_bb0295","doi-asserted-by":"crossref","first-page":"19142","DOI":"10.1039\/D3SC06343G","article-title":"Serine phosphorylation mimics of A\u03b2 form distinct, non-cross-seeding fibril morphs","volume":"15","author":"Sanagavarapu","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.lfs.2026.124397_bb0300","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1038\/emboj.2011.138","article-title":"Extracellular phosphorylation of the amyloid \u03b2-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer\u2019s disease","volume":"30","author":"Kumar","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.lfs.2026.124397_bb0305","doi-asserted-by":"crossref","first-page":"16059","DOI":"10.1074\/jbc.M116.728956","article-title":"Phosphorylation Interferes with Maturation of Amyloid-\u03b2 Fibrillar Structure in the N Terminus","volume":"291","author":"Rezaei-Ghaleh","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0310","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1021\/acschemneuro.0c00541","article-title":"Phosphorylation Promotes A\u03b225-35 Peptide Aggregation within the DMPC Bilayer","volume":"11","author":"Khayat","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.lfs.2026.124397_bb0315","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00401-016-1546-0","article-title":"Phosphorylation of the amyloid \u03b2-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity","volume":"131","author":"Kumar","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.lfs.2026.124397_bb0320","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1097\/00001756-200112040-00047","article-title":"Phosphorylation of amyloid-beta at the serine 26 residue by human cdc2 kinase","volume":"12","author":"Milton","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.lfs.2026.124397_bb0325","article-title":"Phosphorylation and Dephosphorylation of Beta-Amyloid Peptide in Model Cell Cultures: The Role of Cellular Protein Kinases and Phosphatases","volume":"13","author":"Barykin","year":"2023","journal-title":"Life (Basel)."},{"key":"10.1016\/j.lfs.2026.124397_bb0330","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13195-024-01600-x","article-title":"Blockade of brain alkaline phosphatase efficiently reduces amyloid-\u03b2 plaque burden and associated cognitive impairment","volume":"16","author":"Soria-Tobar","year":"2024","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.lfs.2026.124397_bb0335","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.neuron.2011.07.001","article-title":"Nitration of tyrosine 10 critically enhances amyloid \u03b2 aggregation and plaque formation","volume":"71","author":"Kummer","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.lfs.2026.124397_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.619836","article-title":"Insights Into the Mechanism of Tyrosine Nitration in Preventing \u03b2-Amyloid Aggregation in Alzheimer\u2019s Disease","volume":"14","author":"Zhao","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2026.124397_bb0345","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1021\/acschemneuro.4c00284","article-title":"Red-Light-Photosensitized Tyrosine 10 Nitration of \u03b2-Amyloid(1-42) Diverts the Protein from Forming Toxic Aggregates","volume":"15","author":"Basile","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.lfs.2026.124397_bb0350","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00775-011-0842-3","article-title":"Amyloid beta-heme peroxidase promoted protein nitrotyrosination: relevance to widespread protein nitration in Alzheimer\u2019s disease","volume":"17","author":"Yuan","year":"2012","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0355","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/S0021-9258(18)53661-9","article-title":"Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease","volume":"268","author":"Roher","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0360","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.bbrc.2007.10.014","article-title":"Racemization of the amyloidal beta Asp1 residue blocks the acceleration of fibril formation caused by racemization of the Asp23 residue","volume":"364","author":"Sakai-Kato","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2026.124397_bb0365","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1620\/tjem.174.251","article-title":"Racemization: its biological significance on neuropathogenesis of Alzheimer\u2019s disease","volume":"174","author":"Mori","year":"1994","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.lfs.2026.124397_bb0370","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s12640-013-9399-y","article-title":"Peripherally applied synthetic peptide isoAsp7-A\u03b2(1-42) triggers cerebral \u03b2-amyloidosis","volume":"24","author":"Kozin","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.lfs.2026.124397_bb0375","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13195-020-00719-x","article-title":"Targeting isoaspartate-modified A\u03b2 rescues behavioral deficits in transgenic mice with Alzheimer\u2019s disease-like pathology","volume":"12","author":"Gnoth","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.lfs.2026.124397_bb0380","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1271\/bbb.120797","article-title":"Racemization of the aspartic acid residue of amyloid-\u03b2 peptide by a radical reaction","volume":"77","author":"Tambo","year":"2013","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.lfs.2026.124397_bb0385","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/ijpvm.IJPVM_48_19","article-title":"Trace Elements in Human Nutrition (II) - An Update","volume":"11","author":"Mehri","year":"2020","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.lfs.2026.124397_bb0390","series-title":"Alzheimer's Disease, Codon Publications Copyright: The Authors","article-title":"The Role of Trace Metals in Alzheimer's Disease","author":"De Benedictis","year":"2019"},{"key":"10.1016\/j.lfs.2026.124397_bb0395","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1039\/D2CB00208F","article-title":"Current understanding of metal-dependent amyloid-\u03b2 aggregation and toxicity","volume":"4","author":"Yi","year":"2023","journal-title":"RSC chemical biology."},{"key":"10.1016\/j.lfs.2026.124397_bb0400","doi-asserted-by":"crossref","first-page":"10916","DOI":"10.1007\/s12035-024-04256-8","article-title":"Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer\u2019s Disease","volume":"61","author":"Singh","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2026.124397_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/866da844-12ad-4fef-a57e-92a4549e035c","article-title":"The zinc dyshomeostasis hypothesis of Alzheimer's disease","volume":"7","author":"Craddock","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2026.124397_bb0410","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1039\/B813398K","article-title":"Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide","author":"Faller","year":"2009","journal-title":"Dalton transactions (Cambridge, England : 2003)."},{"key":"10.1016\/j.lfs.2026.124397_bb0415","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bpj.2011.11.4006","article-title":"NMR solution structure of rat a\u03b2(1-16): toward understanding the mechanism of rats\u2019 resistance to Alzheimer\u2019s disease","volume":"102","author":"Istrate","year":"2012","journal-title":"Biophys. J."},{"key":"10.1016\/j.lfs.2026.124397_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106301","article-title":"The metal ion hypothesis of Alzheimer\u2019s disease and the anti-neuroinflammatory effect of metal chelators","volume":"131","author":"Chen","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0425","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1074\/jbc.M110.158980","article-title":"Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation","volume":"286","author":"Liu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0430","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.biocel.2011.02.009","article-title":"Aluminum, copper, iron and zinc differentially alter amyloid-A\u03b2(1-42) aggregation and toxicity","volume":"43","author":"Bolognin","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.lfs.2026.124397_bb0435","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1021\/acs.accounts.3c00370","article-title":"Metal Binding of Alzheimer\u2019s Amyloid-\u03b2 and Its Effect on Peptide Self-Assembly","volume":"56","author":"Abelein","year":"2023","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.lfs.2026.124397_bb0440","doi-asserted-by":"crossref","first-page":"292","DOI":"10.15698\/cst2018.11.162","article-title":"Making the final cut: pathogenic amyloid-\u03b2 peptide generation by \u03b3-secretase","volume":"2","author":"Steiner","year":"2018","journal-title":"Cell stress."},{"key":"10.1016\/j.lfs.2026.124397_bb0445","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/jnc.13443","article-title":"Membrane-bound tetramer and trimer A\u03b2 oligomeric species correlate with toxicity towards cultured neurons","volume":"136","author":"Jana","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2026.124397_bb0450","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1021\/acs.biochem.5b01259","article-title":"Monomeric A\u03b21\u201340 and A\u03b21\u201342 Peptides in Solution Adopt Very Similar Ramachandran Map Distributions That Closely Resemble Random Coil","volume":"55","author":"Roche","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.lfs.2026.124397_bb0455","doi-asserted-by":"crossref","first-page":"18340","DOI":"10.1021\/jacs.3c03980","article-title":"A Hairpin Motif in the Amyloid-\u03b2 Peptide Is Important for Formation of Disease-Related Oligomers","volume":"145","author":"Khaled","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.lfs.2026.124397_bb0460","first-page":"1581","article-title":"On the nucleation of amyloid beta-protein monomer folding, Protein science\u202f: a publication of the Protein","volume":"14","author":"Lazo","year":"2005","journal-title":"Society"},{"key":"10.1016\/j.lfs.2026.124397_bb0465","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jmb.2008.09.039","article-title":"Amyloid \u03b2-Protein Monomer Folding: Free-Energy Surfaces Reveal Alloform-Specific Differences","volume":"384","author":"Yang","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.lfs.2026.124397_bb0470","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bbrc.2011.06.133","article-title":"A partially folded structure of amyloid-beta(1-40) in an aqueous environment","volume":"411","author":"Vivekanandan","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2026.124397_bb0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150267","article-title":"Monomeric Amyloid Beta Peptide in Hexafluoroisopropanol Detected by Small Angle Neutron Scattering","volume":"11","author":"Zhang-Haagen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2026.124397_bb0480","article-title":"Exploring the early stages of the amyloid A\u03b2(1-42) peptide aggregation process: an NMR study","volume":"14","author":"Santoro","year":"2021","journal-title":"Pharmaceuticals (Basel, Switz.)."},{"key":"10.1016\/j.lfs.2026.124397_bb0485","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bpj.2022.12.020","article-title":"Differentiation of subnucleus-sized oligomers and nucleation-competent assemblies of the A\u03b2 peptide","volume":"122","author":"Pauly","year":"2023","journal-title":"Biophys. J."},{"key":"10.1016\/j.lfs.2026.124397_bb0490","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1074-5521(97)90255-6","article-title":"Observation of metastable A\u03b2 amyloid protofibrils by atomic force microscopy","volume":"4","author":"Harper","year":"1997","journal-title":"Chem. Biol."},{"key":"10.1016\/j.lfs.2026.124397_bb0495","doi-asserted-by":"crossref","first-page":"10478","DOI":"10.1021\/acs.jpcb.5b05593","article-title":"Structures of the Alzheimer\u2019s Wild-Type A\u03b21-40 Dimer from Atomistic Simulations","volume":"119","author":"Tarus","year":"2015","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.lfs.2026.124397_bb0500","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1021\/jacs.6b11748","article-title":"Stabilization, Assembly, and Toxicity of Trimers Derived from A\u03b2","volume":"139","author":"Kreutzer","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.lfs.2026.124397_bb0505","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bpj.2016.08.001","article-title":"Molecular Dynamics Simulations of Amyloid \u03b2-Peptide (1-42): Tetramer Formation and Membrane Interactions","volume":"111","author":"Brown","year":"2016","journal-title":"Biophys. J."},{"key":"10.1016\/j.lfs.2026.124397_bb0510","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1021\/acs.jpcb.9b01206","article-title":"Tetrameric A\u03b240 and A\u03b242 \u03b2-barrel structures by extensive atomistic simulations. I. In a bilayer mimicking a neuronal membrane","volume":"123","author":"Nguyen","year":"2019","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.lfs.2026.124397_bb0515","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1038\/s41467-020-16566-1","article-title":"A\u03b2(1-42) tetramer and octamer structures reveal edge conductivity pores as a mechanism for membrane damage","volume":"11","author":"Ciudad","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2026.124397_bb0520","first-page":"9220","article-title":"High molecular weight amyloid \u03b2(1-42) oligomers induce neurotoxicity via plasma membrane damage, FASEB journal\u202f: official publication of the Federation of American Societies for","volume":"33","author":"Yasumoto","year":"2019","journal-title":"Exp. Biol."},{"key":"10.1016\/j.lfs.2026.124397_bb0525","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1021\/cn2001238","article-title":"Isolated amyloid-\u03b2(1-42) protofibrils, but not isolated fibrils, are robust stimulators of microglia","volume":"3","author":"Paranjape","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.lfs.2026.124397_bb0530","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1021\/bi500957g","article-title":"Biophysical comparison of soluble amyloid-\u03b2(1-42) protofibrils, oligomers, and protofilaments","volume":"54","author":"Nichols","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.lfs.2026.124397_bb0535","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/anie.201007265","article-title":"Solid-state NMR spectroscopic investigation of A\u03b2 protofibrils: implication of a \u03b2-sheet remodeling upon maturation into terminal amyloid fibrils","volume":"50","author":"Scheidt","year":"2011","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.lfs.2026.124397_bb0540","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/jsbi.2000.4259","article-title":"Studies on the in vitro assembly of a beta 1-40: implications for the search for a beta fibril formation inhibitors","volume":"130","author":"Goldsbury","year":"2000","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.lfs.2026.124397_bb0545","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1039\/D1SC06337E","article-title":"Anatomy and formation mechanisms of early amyloid-\u03b2 oligomers with lateral branching: graph network analysis on large-scale simulations","volume":"13","author":"Yuan","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.lfs.2026.124397_bb0550","doi-asserted-by":"crossref","unstructured":"L. Gremer, D. Sch\u00f6lzel, C. Schenk, E. Reinartz, J. Labahn, R.B.G. Ravelli, M. Tusche, C. Lopez-Iglesias, W. Hoyer, H. Heise, D. Willbold, G.F. Schr\u00f6der, Fibril structure of amyloid-\u03b2(1\u201342) by cryo-electron microscopy, Science (New York, N.Y.). 358 (2017) 116\u2013119. doi:https:\/\/doi.org\/10.1126\/science.aao2825.","DOI":"10.1126\/science.aao2825"},{"key":"10.1016\/j.lfs.2026.124397_bb0555","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.biochem.66.1.385","article-title":"Models of amyloid seeding in Alzheimer\u2019s disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins","volume":"66","author":"Harper","year":"1997","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.lfs.2026.124397_bb0560","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","article-title":"The amyloid state of proteins in human diseases","volume":"148","author":"Eisenberg","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2026.124397_bb0565","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1021\/jacs.6b05129","article-title":"Atomic Resolution Structure of Monomorphic A\u03b242 Amyloid Fibrils","volume":"138","author":"Colvin","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.lfs.2026.124397_bb0570","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.1073\/pnas.1218402110","article-title":"Proliferation of amyloid-\u03b242 aggregates occurs through a secondary nucleation mechanism","volume":"110","author":"Cohen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2026.124397_bb0575","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1471-4159.2010.06997.x","article-title":"Ganglioside-mediated aggregation of amyloid \u03b2-proteins (A\u03b2): comparison between A\u03b2-(1-42) and A\u03b2-(1-40)","volume":"116","author":"Ogawa","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2026.124397_bb0580","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1039\/D4CB00189C","article-title":"Ganglioside lipids inhibit the aggregation of the Alzheimer's amyloid-\u03b2 peptide","volume":"6","author":"Toprakcioglu","year":"2025","journal-title":"RSC Chem Biol."},{"key":"10.1016\/j.lfs.2026.124397_bb0585","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1073\/pnas.222681699","article-title":"Amyloid \u03b2-protein (A\u03b2) assembly: A\u03b240 and A\u03b242 oligomerize through distinct pathways","volume":"100","author":"Bitan","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2026.124397_bb0590","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5607\/en22004","article-title":"Physiological Roles of Monomeric Amyloid-\u03b2 and Implications for Alzheimer's Disease Therapeutics","volume":"31","author":"Jeong","year":"2022","journal-title":"Experimental neurobiology."},{"issue":"2","key":"10.1016\/j.lfs.2026.124397_bb0595","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/biophysica2020010","article-title":"Amyloid-\u00df Oligomers: Multiple Moving Targets","volume":"2","author":"Shea","year":"2022","journal-title":"Biophysica"},{"key":"10.1016\/j.lfs.2026.124397_bb0600","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1742-4658.2010.07568.x","article-title":"Amyloid oligomers: formation and toxicity of A\u03b2 oligomers","volume":"277","author":"Sakono","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.lfs.2026.124397_bb0605","doi-asserted-by":"crossref","first-page":"22122","DOI":"10.1074\/jbc.M111.236257","article-title":"Amyloid-\u03b2 annular protofibrils evade fibrillar fate in Alzheimer disease brain","volume":"286","author":"Lasagna-Reeves","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0610","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adx9030","article-title":"Amyloid-\u03b2 oligomers, curvilinear and annular assemblies, imaged by cryo-ET, cryo-EM, and AFM","volume":"11","author":"Liang","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.lfs.2026.124397_bb0615","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1529\/biophysj.107.110148","article-title":"Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process","volume":"93","author":"Jang","year":"2007","journal-title":"Biophys. J."},{"key":"10.1016\/j.lfs.2026.124397_bb0620","doi-asserted-by":"crossref","first-page":"22364","DOI":"10.1074\/jbc.272.35.22364","article-title":"Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate","volume":"272","author":"Walsh","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0625","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1073\/pnas.1219476110","article-title":"Atomic structure and hierarchical assembly of a cross-\u03b2 amyloid fibril","volume":"110","author":"Fitzpatrick","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2026.124397_bb0630","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature03680","article-title":"Structure of the cross-beta spine of amyloid-like fibrils","volume":"435","author":"Nelson","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2026.124397_bb0635","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40659-022-00404-3","article-title":"Inflammation context in Alzheimer\u2019s disease, a relationship intricate to define","volume":"55","author":"Novoa","year":"2022","journal-title":"Biol. Res."},{"key":"10.1016\/j.lfs.2026.124397_bb0640","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.sbi.2019.09.001","article-title":"Amyloid structures: much more than just a cross-\u03b2 fold","volume":"60","author":"Gallardo","year":"2020","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.lfs.2026.124397_bb0645","doi-asserted-by":"crossref","unstructured":"M. Wong-Guerra, C. Calfio, R.B. Maccioni, L.E. Rojo, Revisiting the neuroinflammation hypothesis in Alzheimer'\u2019s disease: a focus on the druggability of current targets, Volume 14 - 2023 (2023). doi:https:\/\/doi.org\/10.3389\/fphar.2023.1161850.","DOI":"10.3389\/fphar.2023.1161850"},{"key":"10.1016\/j.lfs.2026.124397_bb0650","doi-asserted-by":"crossref","first-page":"340ra372","DOI":"10.1126\/scitranslmed.aaf1059","article-title":"Amyloid-\u03b2 peptide protects against microbial infection in mouse and worm models of Alzheimer\u2019s disease","volume":"8","author":"Kumar","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lfs.2026.124397_bb0655","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41467-018-07991-4","article-title":"Microglia and amyloid precursor protein coordinate control of transient Candida cerebritis with memory deficits","volume":"10","author":"Wu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2026.124397_bb0660","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3233\/JAD-2010-1230","article-title":"A physiological role for amyloid-beta protein:enhancement of learning and memory","volume":"19","author":"Morley","year":"2010","journal-title":"Journal of Alzheimer's disease : JAD."},{"key":"10.1016\/j.lfs.2026.124397_bb0665","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ana.22313","article-title":"Endogenous amyloid-\u03b2 is necessary for hippocampal synaptic plasticity and memory","volume":"69","author":"Puzzo","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.lfs.2026.124397_bb0670","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1523\/JNEUROSCI.2692-08.2008","article-title":"Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus","volume":"28","author":"Puzzo","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2026.124397_bb0675","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function","volume":"37","author":"Kamenetz","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.lfs.2026.124397_bb0680","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/jnr.21054","article-title":"Role of potassium channels in Abeta(1-40)-activated apoptotic pathway in cultured cortical neurons","volume":"84","author":"Yu","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.lfs.2026.124397_bb0685","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12603-019-1162-5","article-title":"Editorial: What is the Physiological Function of Amyloid-Beta Protein?","volume":"23","author":"Morley","year":"2019","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.lfs.2026.124397_bb0690","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1523\/JNEUROSCI.23-13-05531.2003","article-title":"The production of amyloid beta peptide is a critical requirement for the viability of central neurons, The Journal of neuroscience\u202f: the official journal of the Society for","volume":"23","author":"Plant","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2026.124397_bb0695","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.2218531","article-title":"Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides","volume":"250","author":"Yankner","year":"1990","journal-title":"Science (N. Y.)"},{"key":"10.1016\/j.lfs.2026.124397_bb0700","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1523\/JNEUROSCI.0974-04.2004","article-title":"Neurogenic effect of beta-amyloid peptide in the development of neural stem cells","volume":"24","author":"L\u00f3pez-Toledano","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2026.124397_bb0705","doi-asserted-by":"crossref","first-page":"18169","DOI":"10.1074\/jbc.M313572200","article-title":"Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer\u2019s disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques","volume":"279","author":"Syme","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0710","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1113\/jphysiol.2005.089276","article-title":"Visualization of transmitter release with zinc fluorescence detection at the mouse hippocampal mossy fibre synapse","volume":"566","author":"Qian","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.lfs.2026.124397_bb0715","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","article-title":"Rapid restoration of cognition in Alzheimer\u2019s transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta","volume":"59","author":"Adlard","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.lfs.2026.124397_bb0720","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/brain\/awt062","article-title":"Brain amyloid-\u03b2 oligomers in ageing and Alzheimer's disease","volume":"136","author":"Lesn\u00e9","year":"2013","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.lfs.2026.124397_bb0725","article-title":"A\u03b2 oligomers peak in early stages of Alzheimer's disease preceding tau pathology","volume":"16","author":"Bl\u00f6meke","year":"2024","journal-title":"Alzheimer's & dementia (Amsterdam, Netherlands)."},{"key":"10.1016\/j.lfs.2026.124397_bb0730","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1750-3639.2009.00321.x","article-title":"Oligomeric Abeta in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy","volume":"20","author":"van Helmond","year":"2010","journal-title":"Brain pathology (Zurich, Switzerland)."},{"key":"10.1016\/j.lfs.2026.124397_bb0735","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1749-6632.2000.tb06366.x","article-title":"Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage","volume":"903","author":"McCarron","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.lfs.2026.124397_bb0740","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nn.2476","article-title":"Amyloid beta from axons and dendrites reduces local spine number and plasticity","volume":"13","author":"Wei","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.lfs.2026.124397_bb0745","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s40478-018-0611-4","article-title":"NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (A\u03b2) overexpressing mice","volume":"6","author":"M\u00fcller","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.lfs.2026.124397_bb0750","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3233\/JAD-170879","article-title":"Amyloid-\u03b2 Induces AMPA Receptor Ubiquitination and Degradation in Primary Neurons and Human Brains of Alzheimer's Disease","volume":"62","author":"Zhang","year":"2018","journal-title":"Journal of Alzheimer's disease : JAD."},{"key":"10.1016\/j.lfs.2026.124397_bb0755","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1096\/fj.10-156661","article-title":"Binding of amyloid beta peptide to beta2 adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity","volume":"24","author":"Wang","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2026.124397_bb0760","doi-asserted-by":"crossref","first-page":"10627","DOI":"10.1523\/JNEUROSCI.0620-09.2009","article-title":"The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo","volume":"29","author":"Knowles","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2026.124397_bb0765","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.biocel.2015.04.013","article-title":"Mitogen-activated protein kinase signaling pathways promote low-density lipoprotein receptor-related protein 1-mediated internalization of beta-amyloid protein in primary cortical neurons","volume":"64","author":"Yang","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.lfs.2026.124397_bb0770","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neurobiolaging.2007.02.029","article-title":"Alzheimer\u2019s disease-type neuronal tau hyperphosphorylation induced by A beta oligomers","volume":"29","author":"De Felice","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.lfs.2026.124397_bb0775","doi-asserted-by":"crossref","first-page":"11938","DOI":"10.1523\/JNEUROSCI.2357-10.2010","article-title":"Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines, The Journal of neuroscience\u202f: the official journal of the Society for","volume":"30","author":"Zempel","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2026.124397_bb0780","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","volume":"29","author":"Ma","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2026.124397_bb0785","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1074\/jbc.M116.762526","article-title":"Ion Channel Formation by Amyloid-\u03b242 Oligomers but Not Amyloid-\u03b240 in Cellular Membranes","volume":"292","author":"Bode","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0790","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1074\/jbc.M109.030023","article-title":"Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure","volume":"285","author":"Parodi","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0795","article-title":"Imaging Amyloid-\u03b2 Membrane Interactions: Ion-Channel Pores and Lipid-Bilayer Permeability in Alzheimer\u2019s Disease","volume":"135","author":"Viles","year":"2023","journal-title":"Angew. Chem. Weinheim Bergstr. Ger."},{"key":"10.1016\/j.lfs.2026.124397_bb0800","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.1074\/jbc.AC118.007195","article-title":"Amyloid-\u03b2 oligomers have a profound detergent-like effect on lipid membrane bilayers, imaged by atomic force and electron microscopy","volume":"294","author":"Bode","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0805","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/jnr.22640","article-title":"Intraneuronal amyloid \u03b2 oligomers cause cell death via endoplasmic reticulum stress, endosomal\/lysosomal leakage, and mitochondrial dysfunction in vivo","volume":"89","author":"Umeda","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.lfs.2026.124397_bb0810","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13024-016-0098-z","article-title":"Accumulation of amyloid-\u03b2 by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons","volume":"11","author":"S\u00f6llvander","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.lfs.2026.124397_bb0815","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","article-title":"Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders","volume":"26","author":"Caughey","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.lfs.2026.124397_bb0820","doi-asserted-by":"crossref","first-page":"11665","DOI":"10.1074\/jbc.M111.282533","article-title":"Microcin amyloid fibrils A are reservoir of toxic oligomeric species","volume":"287","author":"Shahnawaz","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0825","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1021\/acschemneuro.4c00835","article-title":"Cytotoxicity of Amyloid \u03b21-42 Fibrils to Brain Immune Cells","volume":"16","author":"Matveyenka","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.lfs.2026.124397_bb0830","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1523\/JNEUROSCI.21-15-05703.2001","article-title":"Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits","volume":"21","author":"St\u00e9phan","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2026.124397_bb0835","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1073\/pnas.1423174112","article-title":"pH-induced molecular shedding drives the formation of amyloid fibril-derived oligomers","volume":"112","author":"Tipping","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2026.124397_bb0840","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/s41467-023-43822-x","article-title":"Cryo-EM structures of lipidic fibrils of amyloid-\u03b2 (1-40)","volume":"15","author":"Frieg","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2026.124397_bb0845","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1073\/pnas.0901229106","article-title":"Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta","volume":"106","author":"Pigino","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2026.124397_bb0850","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2026.124397_bb0855","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1038\/emboj.2013.207","article-title":"Amyloid-\u03b2 oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin","volume":"32","author":"Zempel","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.lfs.2026.124397_bb0860","first-page":"618","article-title":"Inhibition of BACE1 for therapeutic use in Alzheimer\u2019s disease","volume":"3","author":"Luo","year":"2010","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.lfs.2026.124397_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101496","article-title":"Past, present and future of therapeutic strategies against amyloid-\u03b2 peptides in Alzheimer\u2019s disease: a systematic review","volume":"72","author":"Jeremic","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.lfs.2026.124397_bb0870","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer\u2019s Disease","volume":"378","author":"Egan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2026.124397_bb0875","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13195-020-00614-5","article-title":"Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer\u2019s disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study","volume":"12","author":"Novak","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.lfs.2026.124397_bb0880","doi-asserted-by":"crossref","first-page":"164","DOI":"10.35772\/ghm.2024.01033","article-title":"BACE1 inhibitor drugs for the treatment of Alzheimer's disease: Lessons learned, challenges to overcome, and future prospects(\u2020)","volume":"6","author":"Ghosh","year":"2024","journal-title":"Global health & medicine."},{"key":"10.1016\/j.lfs.2026.124397_bb0885","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fnmol.2020.00137","article-title":"Targeting Amyloidogenic Processing of APP in Alzheimer's Disease","volume":"13","author":"Zhao","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2026.124397_bb0890","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1021\/bi301137h","article-title":"BMS-708,163 targets presenilin and lacks notch-sparing activity","volume":"51","author":"Crump","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.lfs.2026.124397_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114169","article-title":"Small molecules targeting \u03b3-secretase and their potential biological applications","volume":"232","author":"Wen","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb0900","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2026.124397_bb0905","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/jnc.13608","article-title":"A retrospective analysis of the Alzheimer\u2019s disease vaccine progress - The critical need for new development strategies","volume":"137","author":"Marciani","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2026.124397_bb0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104665","article-title":"Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer\u2019s disease: a randomised, double-blind, placebo-controlled, phase 2a study","volume":"94","author":"Yu","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lfs.2026.124397_bb0915","doi-asserted-by":"crossref","DOI":"10.1002\/alz.089036","article-title":"Active immunotherapy, ACI-24.060, induces anti-Abeta antibodies with binding profiles mirroring clinically validated monoclonal antibodies","volume":"20","author":"Fiorini","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.lfs.2026.124397_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104823","article-title":"Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials","volume":"139","author":"Petrushina","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2026.124397_bb0925","article-title":"Promising results from Alzheimer\u2019s disease passive immunotherapy support the development of a preventive vaccine","volume":"2019","author":"Marciani","year":"2019","journal-title":"Research (Washington, D.C.)."},{"key":"10.1016\/j.lfs.2026.124397_bb0930","doi-asserted-by":"crossref","DOI":"10.1002\/alz.065633","article-title":"AB1601 topline results \u2013 Phase 2 study of ABvac40 in patients with amnestic mild cognitive impairment (a-MCI) or very mild Alzheimer\u2019s Disease (Vm-AD)","volume":"18","author":"Molina","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.lfs.2026.124397_bb0935","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nbd.2003.09.015","article-title":"Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration","volume":"15","author":"Wilcock","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2026.124397_bb0940","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12883-017-0850-1","article-title":"Bapineuzumab for mild to moderate Alzheimer\u2019s disease: a meta-analysis of randomized controlled trials","volume":"17","author":"Abushouk","year":"2017","journal-title":"BMC Neurol."},{"key":"10.1016\/j.lfs.2026.124397_bb0945","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1038\/s41598-018-24501-0","article-title":"Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-\u03b2","volume":"8","author":"Arndt","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2026.124397_bb0950","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of Aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.lfs.2026.124397_bb0955","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2026.124397_bb0960","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3233\/JAD-215065","article-title":"A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer's Disease","volume":"83","author":"Mukhopadhyay","year":"2021","journal-title":"Journal of Alzheimer's disease : JAD."},{"key":"10.1016\/j.lfs.2026.124397_bb0965","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","article-title":"Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer\u2019s Disease","volume":"20","author":"S\u00f6derberg","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.lfs.2026.124397_bb0970","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer\u2019s Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2026.124397_bb0975","first-page":"1359","article-title":"Profile of gantenerumab and its potential in the treatment of Alzheimer\u2019s disease","volume":"7","author":"Novakovic","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.lfs.2026.124397_bb0980","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-2011-110977","article-title":"Gantenerumab: a novel human anti-A\u03b2 antibody demonstrates sustained cerebral amyloid-\u03b2 binding and elicits cell-mediated removal of human amyloid-\u03b2","volume":"28","author":"Bohrmann","year":"2012","journal-title":"Journal of Alzheimer's disease : JAD."},{"key":"10.1016\/j.lfs.2026.124397_bb0985","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJMoa2304430","article-title":"Two Phase 3 Trials of Gantenerumab in Early Alzheimer\u2019s Disease","volume":"389","author":"Bateman","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2026.124397_bb0990","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamaneurol.2024.3937","article-title":"Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease","volume":"82","author":"Salloway","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.lfs.2026.124397_bb0995","doi-asserted-by":"crossref","first-page":"17082","DOI":"10.1016\/S0021-9258(18)41896-0","article-title":"Mass spectrometry of purified amyloid beta protein in Alzheimer\u2019s disease","volume":"267","author":"Mori","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100150","article-title":"Donanemab: Appropriate use recommendations","volume":"12","author":"Rabinovici","year":"2025","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.lfs.2026.124397_bb1005","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jamaneurol.2025.3869","article-title":"Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical Trial","volume":"82","author":"Lu","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.lfs.2026.124397_bb1010","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial","volume":"330","author":"Sims","year":"2023","journal-title":"Jama"},{"key":"10.1016\/j.lfs.2026.124397_bb1015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamaneurol.2025.0065","article-title":"Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials","volume":"82","author":"Zimmer","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.lfs.2026.124397_bb1020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/17460441.2024.2348142","article-title":"Lessons learned from the failure of solanezumab as a prospective treatment strategy for Alzheimer's disease","volume":"19","author":"Lozupone","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.lfs.2026.124397_bb1025","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1038\/srep09649","article-title":"Molecular basis for mid-region amyloid-\u03b2 capture by leading Alzheimer\u2019s disease immunotherapies","volume":"5","author":"Crespi","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2026.124397_bb1030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jmb.2011.11.047","article-title":"Structural basis of C-terminal \u03b2-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer\u2019s disease","volume":"421","author":"La Porte","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.lfs.2026.124397_bb1035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jalz.2011.09.224","article-title":"Safety and biomarker effects of solanezumab in patients with Alzheimer\u2019s disease","volume":"8","author":"Farlow","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.lfs.2026.124397_bb1040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of solanezumab for mild dementia due to Alzheimer\u2019s disease","volume":"378","author":"Honig","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2026.124397_bb1045","doi-asserted-by":"crossref","DOI":"10.1038\/srep39374","article-title":"Structure of Crenezumab Complex with A\u03b2 Shows Loss of \u03b2-Hairpin","volume":"6","author":"Ultsch","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2026.124397_bb1050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13195-019-0553-5","article-title":"Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric A\u03b2","volume":"11","author":"Meilandt","year":"2019","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.lfs.2026.124397_bb1055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13195-018-0424-5","article-title":"Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer\u2019s disease (BLAZE)","volume":"10","author":"Salloway","year":"2018","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.lfs.2026.124397_bb1060","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/jamaneurol.2022.2909","article-title":"Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials","volume":"79","author":"Ostrowitzki","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.lfs.2026.124397_bb1065","doi-asserted-by":"crossref","first-page":"E200","DOI":"10.1073\/pnas.1615613114","article-title":"Systematic development of small molecules to inhibit specific microscopic steps of A\u03b242 aggregation in Alzheimer's disease","volume":"114","author":"Habchi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2026.124397_bb1070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101483","article-title":"The amyloid-\u03b2(1-42)-oligomer interacting peptide D-AIP possesses favorable biostability, pharmacokinetics, and brain region distribution","volume":"298","author":"Shobo","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124397_bb1075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153035","article-title":"Optimization of the All-D Peptide D3 for A\u03b2 Oligomer Elimination","volume":"11","author":"Klein","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2026.124397_bb1080","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22101693","article-title":"Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer\u2019s Disease","volume":"22","author":"Kutzsche","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2026.124397_bb1085","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s40263-024-01093-0","article-title":"Targeting Biometals in Alzheimer\u2019s Disease with Metal Chelating Agents Including Coumarin Derivatives","volume":"38","author":"Guck\u00fd","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.lfs.2026.124397_bb1090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s42003-019-0612-2","article-title":"Autocatalytic amplification of Alzheimer-associated A\u03b242 peptide aggregation in human cerebrospinal fluid","volume":"2","author":"Frankel","year":"2019","journal-title":"Commun Biol."},{"key":"10.1016\/j.lfs.2026.124397_bb1095","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1126\/science.1131864","article-title":"Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host","volume":"313","author":"Meyer-Luehmann","year":"2006","journal-title":"Science"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526002067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526002067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:48:11Z","timestamp":1778723291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320526002067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":219,"alternative-id":["S0024320526002067"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124397","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The aggregation of amyloid-\u03b2: from condensation, nucleation, and conformation to targeting therapy","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"124397"}}